Retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New in here, I bought in understanding the risk of having manipulators sabottaging whatever the pps of the stock should be or not (the pleasure of playing pinkies). For the moment I consider that 'bet' to be a long shot blind date ???
I bought in however having read the 03/17/2022 NR and noticing that currently (1 o'clock today) the picture of this stock did look as follows:
Shares Outstanding : 799,197,561
PPS : ,0023 (boughe at 22)
MC : 1,84M (Many pet shops justify such a MC)
Such a market cap seems extremely low for a company looking at a claimed projectected (???) yearly revenue potential of more or less $ 75M sometine in a relatively short term horizon (let's say 1 to 2 years or so).
This being said the company must now start being transparent filing its financials so the market can see what the company really is all about (revenues, expenses, assets, liabilities, ...).
For the moment it looks good but who really knows ???
Companies have 45 days to issue their quarterly reports and 3 months to produce their annual financials.
Why do the small listed companies always (very few exceptions) wait for the very last possible day to produce their reports. I consider that to be a lack of respect for the shareholders.
Companies have 45 days to issue their quarterly reports and 3 months to produce their annual financials.
Why do the small listed companies always (very few exceptions) wait for the very last possible day to produce their reports. I consider that to be a lack of respect for the shareholders.
Companies have 45 days to issue their quarterly reports and 3 months to produce their annual financials.
Why do the small listed companies always (very few exceptions) wait for the very last possible day to produce their reports. I consider that to be a lack of respect for the shareholders.
Companies have 45 days to issue their quarterly reports and 3 months to produce their annual financials.
Why do the small listed companies always (very few exceptions) wait for the very last possible day to produce their reports. I consider that to be a lack of respect for the shareholders.
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer - 03/28/2022 8:30:00 AM
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a definitive agreement (the “Agreement”) dated March 24, 2022 with Praesidio Health Inc. (“Praesidio”). Pursuant to the Agreement, the Company will acquire all of the issued and outstanding shares in the capital of Praesidio (the “Praesidio Shares”) for aggregate consideration of C$4,000,000 in common shares (the “Consideration Shares”) of the Company (the “Transaction”). Upon closing of the Transaction (“Closing”), Praesidio will operate as a wholly-owned subsidiary of the Company.
Praesidio Health (https://www.praesidiohealth.com/) is an industry-leading, Canadian medical research company that develops and validates natural health medicine (“NHM”) using an evidence-based process. Pioneering NHMs and therapeutics, Praesidio Health is actively developing several product candidates for utility in a range of conditions, including post-viral exposure prophylaxis, urological, anxiety/stress, immune booster, and sleep aids. The company employs formulation combinations with and without cannabinoids and/or psilocybin, which opens the opportunity for product development in conjunction with future operations in Israel including direct access to European markets.
The Consideration Shares will be issued in seven tranches, with C$1,000,000 of the Consideration Shares being issued at Closing and C$500,000 of the Consideration Shares being issued every six months thereafter until the third anniversary of the date of Closing. The price of the Consideration Shares will be equal to the volume weighted average of actual trading prices (measured in hundredths of cents) of the common shares in the capital of the Company on the Canadian Securities Exchange (the “CSE”) for the ten consecutive business days prior to the applicable date of issuance. The Consideration Shares will be subject to a 48-month contractual escrow period, which will begin on date of Closing.
The Transaction remains subject to certain closing conditions, including, without limitation, the receipt of all necessary corporate and regulatory approvals and other customary closing conditions. There can be no assurance that the Transaction will be completed as proposed or at all. Closing of the Transaction is expected to occur on or about April 4th, 2022.
The securities of the Company referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.
I today sold 30% of my new share at high profit but, with the generated cash, I hope to buy them back following the publication of our financials next week (may create another temporary drop of the pps).
I like this investment
Not withstanding the hoo-hah as you said, I have an INVESTMENT base (100%) of shares I never touch. I in time have up to 30% more shares i 'kind-of-trade-with' now and then.
Yesterday and today (that's the case for 2 of my stocks) I 'cash-in' some (10% of my BABY today) so I have enough cash on hand next week when I expect FY2021 financials ... In case the market would thereafter give buying opportunities.
BABY is one of my biggest investment, I'm confident but I want to see that this company will not endup being a BETAMAX type investment where a superior product lost the war cause of marketing deficiency. That's what my 'hoo-hah' is all about.
Cashed in 10% of my shares at $1.38. Will now wait for the financials before either buying back in or use my cash somewhere else.
Dilution ???
PPS went down on a volume of 600,000 shares up to now today. That's worth just over $ 400.
Obviously activity is only created by low-pps-chassers and interpretation of what GRST is or not is most of the time the creation of posters having no clue what is or not going on behind the scene.
Till Leon decides to open his books, all we will know is where we stand business wise on a quaterly basis.
Therefore, all we can honestly say is that we right now are invested in a small growing business that could fail for good (what some herein wish for) or become a highly profitable success story (That may explain why there are right now 75,000,000 shares on the bid and no one selling).
Anyone pretending to know more than that is lying.
Obviously a/some manipulator(s) are controlling our pps but I honestly do not believe Shawn to be beind this process. Some other crazy crooks are enjoying blocking the price, most likely accumulating for future profit, buying from shareholders giving up
Some (pessimits) want to only see negatives and dirty tricks looking ahead relative to this stock ... Ridicule
Some (optimists) want to only see positives and successes looking ahead relative to this stock ... Ridicule
I try to be realist:
- GRST is a risky pinky,
- GRST is traded on a dangerous market, manipulated by some,
- GRST has reducing debts and growing revenues,
- GRST is managed by a successful executive
- GRST’S CEO is having significant initial success at reviving a company that was in a deep coma only months ago.
Bottom line:
- If our CEO fails, we will have to write off our bet/investment
- If our CEO succeeds, we are in for quite an interesting financial gain.
IF (???) gas is effectively $6 a gallon un USA, I do not remember the year when gas was selling at the exact same price as the one in US. Here today (PQ) we pay CDN$ 1,88CDN/ltr (4Ltrs/gal and exchange raye at $1,2528).
On March 16 (I had no more shares) the pps dropped as low as 49 and I then decided to buy back in considering the courageous and constructive decision made by our management.
One week later we close at 59 (+ 20%) and if the decision was as responsible as I tought it was, the best is to come.
I have no way of knowing but i must wonder if the decision to cleanup was made :
1- in view of growing from a healthier base or
2-i as a condition to be filled before a buyout.
We shall know soon (following FY2021 financials) which of both great outcomes are in the cards.
GLTA
Some herein do enjoy proposing as negative a picture as one can God and them only understanding why? Hidden agenda, no life type of person, frustrated by past losses shareholders, ...
Personally I try to remenber what GRST is and where it trades but I still prefer to look at what has been achieved within the last 12 months, what commitment our management has demonstrated notwithstanding their very difficullt environment (debt) and where we now stand, remembering where we were last year at the same time.
Trying to look smart, analysing the company as if it was a multi billions business and assuming everything to be negative or the result of a crooked plot, is to say the least ridiculous.
In OTC and looking at pinkies, one has to REALISTICALLY look at a stock with some kind of faith or just walk away from it altogether. Any other behavior would be stupid or worst.
Finally,after I wrote my previous post (MC of US$ 60,000,000 +) I did look FOR FUN at a stock (Irecommended to me but never did own) : Enzolytics Inc, (ENZC) another pinky on the crazy OTC market.
No revenues, more or less 3,000,000,000 O/S, a pps at US$ 0,082 (avg day vol of 5,5M) and a market cap of more than US$ 230,000,000.
If that can be, why not GRST at a MC 25% that large ... 15 months from now?
Many shareswere bought at btween 6 and 0008 or 0009 over the last 4 or 5 months by people looking for an opportunity to make a quick flip generating a very SMALL profit selling these at 0009 to 0011 or 0013. Additionally, for whatever reason(s) manipulators keep working at keeping our pps as low as possible.
These will explain why, whatever the company does within the next 6 months, there will be a lot of resistance against our pps growth. That's why patience will be required and stayng put for all of 2022 will be the smart thing to do, whatever some in here do try to make us believe.
I believe that, if Leon is who I think he is and he does what I think he tries to accomplish, by beguinning to middle 2023 our pps will be in the $0,01 to $0,02 range (MC of $60 to $80 millions, assuming 4 billion O\S).
If Leon keeps working at it as I think he is and will, patience will be seriously rewarded within the next 15 months or so. However (my disclaimer):
- GRST is a risky pinky,
- GRST is traded on a dangerous market, manipulated by some,
- GRST has reducing debts and growing revenues,
- GRST is managed by a successful executive (looking at his past achievements),
I bought my initial shares 1,5 years ago (10-18-2020) and at the time, GRST only was a project in the making, aimed at resurecting a debt crippled company in a deep coma.
Quaterly thereafter, starting on Dec. 31 2020 the company did report revenues of $83,000, $91,000, $96,000 then $860,000. I expect the last quarter to have generated more or less $1,250,000
As per all available signals, Leon seems to be in with a long term operation and I have no doubt that he plan to succeed, the worst apparently behind him.
Now (sorry to repeat it):
- GRST is a risky pinky,
- GRST is traded on a dangerous market, manipulated by some,
- GRST has reducing debts and growing revenues,
- GRST is managed by a successful executive
Do your onw DD and Good luck
For 2 years told about getting agreements with numerous distributors and smo products have been available for sale since early 2021.
I would not effectively be happy with $1.5 million in sales or 33% growth in revenues since Q1 2021 at $1,135,000.
We obviously would have a Marketing/sale issue and I would expect management to rapidly take action.
This being said, let's see the numbers ?
No prediction but for me, $1,5 millions would be disastrous, even if I do not expect a miracle ???
If you are young enough and want to slowly grow your base over many many years, your stock selection based on MC (5+ Billions) may be appropriate and i wish you good luck.
This being said, a riskier but much more short term profit opportunity can be generated thru getting involved early in a small company (startup type) developping a great product. In this case however, management must be smart enough to understand that the successful 'acquisition of market shares' does require much more than a 'good or great' product.
Sometimes, a superior product disappears from the market. This was the case with Betamax expecting to replace VHS. Despite being technologically superior to VHS, Betamax lost market share until it eventually vanished.
Companies that don’t implement effective marketing strategies and techniques that actually benefit their good products will find themselves among the list of marketing failures examples.
Here is what the 2 required teams for a company to succeed:
1 - An R & D team that works to create and define new products and features. To often, the type of persons focussing on the R & D type of activities to often believe that : ‘If a product is good, it will sell’ by itself. Let’s hope our CEO rapidly figures out that this belief is leading to failure.
2 - A marketing team that focuses on bringing those products to market. The marketing team should be qualified to define an overall vision and strategy. This team should then be responsible for defining, building, communicating and executing a product's go-to-market strategy.
The core skills and qualities required within each team are very different. These skills and qualities must be considered before determining which role is right for who within the organisation.
Short of total failure, the story I followed for more than 2 years lead me to believe that buyout will soon be the only available escape route.
I really hope our CEO will understand that soon, finally figuring out that she cannot do it all, successfully, all by herself.
I know she is smart and plan to stick with this stock for a while more but at some point, I will have to see progress made ... and not in 5 years (as she alluded to earlier).
Total quaterly revenues
Déc. 31 2020 : $ 598,000
March 31 2021: $ 1,135,000
June 30 2021: $ 1,114,000
Sept. 30 2021: $1,170,000
Dec. 31 2021: ???
I agree. That's the first time (to my recollection) that he posts something neutral demonstrating his total understanding of the situation.
For whatever reason some one (or some many) decided to buy agressively (12+ time average volume) at 25%+ the pps, within less than 1 hour.
Do not know why (welcome to the crazy OTC market) but it's kind of nice to see.
In any case (contrary to many) I do not plan to sell any of my shares short term.
!0:27
Bid: 20,000,000 at 9 (???)
The financials have not yet been issued (I believe that even a lazy investor knows that). He should also know that all that was announced by the company is that'
'Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”) has submitted the 2021 year-end financial statements to the auditor for review much earlier than in previous years. The segmented information for the ARIA treatment center will show an EBITDA of approximately $163,000 for the fourth quarter which was an approximately 370% increase over the third quarter of 2021.
GLTY
The reason I keep all my shares up to now is that our CEO obviously is an extremely competent 'Scientific' person. and her NR or interviews shows that, this is what she likes and do well (Yesterday's NR reads: '… complete & balanced nutrition drink … have added Omega 3 and Omega 6 fatty acids … We’re continually innovating to respond to … pediatricians expectations, … … free amino acids and over 20+ vitamins and minerals,… received the Clean Label Purity Award Certification).
She however is obviously a very poor communicator (has to read her NR for a 3 minutes interview) and much less competent in the 'Marketing art' skills (Distribution, promoting, selling) addressing general consumers.
Let's see what the next financials will show (I definitely hope to be wrong) but I somehow suspect that saying (Yesterday's NR) 'Following the success of strong market response' and 'success of our flagship Organic Toddler product' will sound, to say the least, an embelishment of what reality really is.
I bought my first shares (2019-12-13) close to 2,5 years ago and now expect to see results and/or acknowledgement that the Achilles' heel of the company has been 'Marketing' and corrective measures are (not considered but) implemented.
Stand to be corrected but I assume it will come out before April 1 ?
At about noon today, there were 27,000,000 shares on the bid at $0,0007 (why not) and 20,000,000 on the ask at $0,0008 (why do people want to sell at that price NOW ???).
Only 64,000 shares were traded at $0,0007 after 2,5 hours of trading (That's $45 worth of shares ... obviously someone forgot to say 'All or nothing')
In the minutes and hours following the release of the financials, I expect a lot of volume and quite a lot of variation of the pps. Bottom line, after a week or so, we shall be back to current situation, escapers and manipulators having done their downward results these people enjoy.
In any case, I'm in for all of 2022 +.
GLTA
As of the last financials I saw (Sept 30), the company had a lot of cash and debtss were not a concern. Therefore one can assume that the risk of running out of money should not be a concern currently. To be noted also that the company.
Additionally, 'Else Nutrition Announces Closing of $17.3 Million Marketed Public Offering of Units (OCT 20, 2021 9:01 AM EDT). The Company intends to use the net proceeds from the Offering to establish a manufacturing facility, acquire inventory, fund research and development including clinical studies, fund sales and marketing and for general corporate purposes.
On January 18, Else announced that it was Establishing Its Own Manufacturing Capacity ... anticipating to produce the first batch of specially processed buckwheat in Q1 2022.
I assume the soon to be issued detailled financials will show that GRST is progressing seriously and results will most likely justify a marketcap of more or less $10 to $15,000,000 (2 to 3 times projected yearly revenues), notwithstanding our debts ($0,003 pps +).
This being said, short term at least, manipulators will keep trying to keep our pps down for some time using the activity of those trying to get out of this stock with minimal loss or gains.
In any case, our next financials will solidify our base and whatever Leon tries to do to create additional business will justify future growth.
Believeing Leon to be darn serious about growing GRST, I intend to let him do his thing for the next year or so and then see if I've been right or long.
That's one reason why I do not directly address frustrated, dishonest poster (no 's') in here anymore.
This morning NR: ‘set to launch Else™ Toddler Omega complete & balanced nutrition drink’ …‘We’re continually innovating’.
An abstract from : https://hbr.org/2005/11/innovation-versus-complexity-what-is-too-much-of-a-good-thing
The fact is, companies have strong incentives to be overly innovative in new product development. … But continual launches of new products add complexity throughout a company’s operations and the costs of managing that complexity makes margins shrink. To maximize profit potential, a company needs to identify the point at which an additional offering destroys more value than it creates.
If our CEO wants to succeed, she must figure out a way to keep doing what she's good at and get help for what seems to be her short comings.
An abstract from my post #4530: THIS WAS JUST THE ILLUSTRATION OF A CONCEPT, following an event impacting ABBOTT
Assuming ABBOTT very seriously want to recuperate from this blow, a scenario could be:
1 - Create an ABBOTT laboratories baby food ‘new subsidiary', financing it with issuing 17,500,000, new shares representing a dilution of less than 1% considering current ABBOTT 1,768,000,000 O/S.
2 - Make NIBF a 2 divisions company:
- One division with an R&D and product development mission and
- another division mandated to market the products developed by the first division.
3 - Make current executives of Else manage the first division
- Assign some current marketing executives from ABBOTT to run the other division.
My point: Our CEO should not reject all 'buyout' offers, she should see if she should not get a good 'Win-Win' situation not giving her full control of everything.
Having half of a big tasty cake is better than having all of a failed distateful one
'Else Nutrition could be huge !' ... That's also what i STILL BELIEVE ...
However our 'Hamutal Yitzhak, CEO & Co-Founder' will have to stop dreaming of the multi billion $$$ business in 5 years. She obviously:
- has a real good grasp at whatever R & D must be,
- seems to have figured out that having a great DISTRIBUTION network is important,
... but I look forward to the proof that she understands what generating revenues means (read MARKETING and SALES).
In business there is a window of opportunity that doesn't wait for success to just happen ... One must exploit it as rapidly as possible and waiting may allow some other companies to do it faster ... even if they do not have the PERFECT PRODUCT.
I still believe the success to be possible but our CEO shall listen to those who can help ... before the window of opportunity fades away.
- 'Following the success of strong market response to its Organic Plant-Based Complete Nutrition for Toddlers' ...
- 'We’re thrilled to build on the success of our flagship Organic Toddler product', ...
Looking forward to read our next financials ??? Let see how 'strong market response' and 'success of our flagship Organic Toddler product' do translate into Revenues ???
Else Nutrition Launches Toddler Omega Complete & Balanced That Will Sell First on Amazon.com & Elsenutrition.com in the Coming Weeks, Followed by Retail Distribution - 03/22/2022 7:00:00 AM
VANCOUVER, British Columbia, March 22, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children nutrition company, is pleased to announce that is it set to launch Else™ Toddler Omega complete & balanced nutrition drink in the coming weeks on Amazon.com and soon after on the Company’s e-store. This will be followed by retail distribution in select retail outlets.
Following the success of strong market response to its Organic Plant-Based Complete Nutrition for Toddlers, the Company has formulated Else™ Toddler Omega, its first toddler product to have added Omega 3 and Omega 6 fatty acids that support brain and eye development, designed to optimize essential proteins, making it complete and balanced.
“We’re thrilled to build on the success of our flagship Organic Toddler product, with a new offering that addresses a larger audience. We’re continually innovating to respond to customers’ requests and pediatricians’ expectations, and this offering is expected to further expand the size and growth rate of our Toddler-targeted business,” said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition.
With essential Omega 3 & 6 for brain development, high quality Plant-Based protein from almonds, buckwheat and supplemented with additional free amino acids and over 20+ vitamins and minerals, Else™ Toddler Omega is a complete and balanced plant-based, clean-label, non-GMO, soy-free, gluten-free, non-organic nutritional drink for toddlers aged 12-36 months. It is designed to support a toddler’s growth and development, as well as promote natural digestion, through its combination of whole food ingredients: almond, buckwheat, and tapioca.
The new product will be offered in 22oz powder cans at a price of $29, to address a wider target market and to maximize its reach. It will be available in multiple formats (single, 2-pack and 4-pack). The product has also received the Clean Label Purity Award Certification, attesting to its quality for meeting the rigorous standards of the Clean Label Projects, which tests products for over 400 impurities including heavy metals, pesticides, and many other contaminants.
I'm probably even older but also look forward to this type of outcome within my remaining months or year (no 'S').
Given a little chance, A market cap in the tens of millions is anything but ridiculous.
This being said:
- GRST is a risky pinky,
- GRST is traded on a dangerous market, manipulated by some,
- GRST has reducing debts and growing revenues,
- GRST is managed by a successful executive (looking at his past achievements),
- GRST’S CEO is having significant initial success at reviving a company that was in a deep coma only months ago.
Bottom line:
- If our CEO fails, we will have to write off our bet/investment (hopefully not having bet the rent to start with)
- If our CEO succeeds, we are in for quite an interesting financial gain.
I personally do not see this as being necessarely a bad news ... I even suggest itCOULD BE a very good news.
‘ it transitions from a focus on top line growth, to a focus of balancing top line growth and profitability ‘.
‘ EXPECT GROWTH WILL SLOW DOWN IN NEAR-TERM IN DIGITAL MARKETING CHANNEL ‘.
Seeing a wall ahead on his road does make start people to slow down and/or change direction, before they hit it.
The crazy thing(s) to do would have been to keep running growing revenues at any costs and diluting shareholders to acquire cash to be spoiled even faster (Many small young companies did that before folding for good).
However, the smart thing to do after realizing that something was going wrong was to create a diagnostic (distribution efficiency and costs are not effective in some sectors) then apply corrective measures to stop the financial bleeding, simultaneously keeping the interesting part of the operation producing profitably.
Before this NR, I personally had developped negative feelings (particularly when the pps went to C$ 0.90+) and sold out (cashed in my profit).
After i saw this NR and the 505 drop in the PPS, I bought back in twice what I owned before based on my above described hypothesis.
P.S.: No specific reason to advance the following other hypothesis but, assuming management was to sellout or merge the business to or with another company, a potential buyer or partner would have requested the defined cleaning up, before proceeding. However, i have absolutely no indication that this hypothesis is or was even considered ???
Morningstar reduced it estimated fair value to C$1.04
Very end of April, Morningstar established VERY (CDN) FAIR VALUE AT C$ 1,44
before dropping it to CS1.28. For whatever reason, shares became trading at (relatively) high pps and I sold mine (chickenned out to be honest) at C$ 0,91
Then came the news and the market sold, out of control, taking our pps down to C$ 0,45 on an extremely high (relatively) volume.
At $0,46, I bought back twice as many shares as I previously had, understanding that even if the company rides a tough time, they took appropriate actions to reestablished a better base from where to go from.
Following the news, Morningstar reduced it estimated fair value to C$1.12 (12,5% lower than the estimated fair value right before the news). On the otherhand, the market sold in panic at The original value of the stock (June 18 2020) a drop of 50%.
Looking forward to the next financials filings but, I somehow belive the market value of the company to be higher than the current market cap of about C$ 50M.
Let's see what's ahead and GLTA
'With the COVID-19 global pandemic continuing to impact ... the continued governmental delays impeding the advancement of its cannabis operation in Israel,'
That never ending situation should justify a corporate update informing the shareholders on the status of that crazy delay and what the plans of the overnment seems to be.